Funding Clears Path for OCU300 Investigational New Drug (IND) Application
Announces License Agreement with University of Illinois at Chicago (UIC) for OCU300; Patent Allowed for OCU200, Novel, Preclinical Biologic in Development for Wet AMD
Company Announces Executive Management, Board and Scientific Advisory Board Updates
Start-up Ocugen eyes new ophthalmology opportunities.
Licensed Two Biological Drug Candidates from University of Colorado.